Sanofi SA major shareholder Sanofi Buys 153,000 Shares (SNY)
Sanofi SA (NYSE:SNY) major shareholder Sanofi purchased 153,000 shares of the stock in a transaction that occurred on Tuesday, July 8th. The shares were purchased at an average price of $311.67 per share, for a total transaction of $47,685,510.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.
Sanofi SA (NYSE:SNY) traded down 0.08% during mid-day trading on Friday, hitting $51.63. 806,378 shares of the company’s stock traded hands. Sanofi SA has a 52 week low of $46.95 and a 52 week high of $54.64. The stock has a 50-day moving average of $53.33 and a 200-day moving average of $51.93. The company has a market cap of $136.4 billion and a price-to-earnings ratio of 26.61.
Sanofi SA (NYSE:SNY) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.81 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.84 by $0.03. On average, analysts predict that Sanofi SA will post $3.53 earnings per share for the current fiscal year.
A number of research firms have recently commented on SNY. Analysts at Zacks reiterated a “neutral” rating on shares of Sanofi SA in a research note on Friday, June 20th. They now have a $57.00 price target on the stock. Finally, analysts at S&P Equity Research reiterated a “hold” rating on shares of Sanofi SA in a research note on Wednesday, April 30th. Seven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Sanofi SA currently has a consensus rating of “Hold” and a consensus target price of $55.00.
Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.